Drugs / Guilu Erxian Jiao
Guilu Erxian Jiao
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06980922 | Jun 2025 → May 2027 expected | end stage renal failure | Chang Gung Memorial Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guilu Erxian Jiao | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06980922 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Guilu Erxian Jiao, a traditional Chinese herbal medicine, can help manage intradialytic hypotension” NCT06980922 ↗ |
| Route | Oral | “Administered orally at 4 grams per day before meals for 4 weeks.” NCT06980922 ↗ |